Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-12-24

Clinical Trial Update: ViewMind Atlas Cognition [NA]

View source ↗

Summary

ViewMind Atlas Cognition (NCT06746844) is currently enrolling by invitation to evaluate cognitive outcomes in individuals with mild cognitive impairment and rel…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: ViewMind | Conditions: MCI, Cognitive Ability, General | NA | Status: ENROLLING_BY_INVITATION